Pancreatic Cancer Research

ResearcherChiba UniversityNo recent work listed

Naohiko Seki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4731-7956; OpenAlex author ID A5090365310. Sources: OpenAlex.

Their work

Papers
11 (first author 7, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2017: 3 papers · 2018: 2 papers · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 11

  1. Coronin 1C, Regulated by Multiple microRNAs, Facilitates Cancer Cell Aggressiveness in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/genes14050995↗
  2. Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.15297↗
  3. Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogenic Genes. Last author DOI 10.3390/cancers12102731↗
  4. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis. Last author DOI 10.3390/ijms21186459↗
  5. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8. First author DOI 10.1038/s10038-019-0584-6↗
  6. Gene Regulation by Antitumor miR-204-5p in Pancreatic Ductal Adenocarcinoma: The Clinical Significance of Direct RACGAP1 Regulation. Co-author DOI 10.3390/cancers11030327↗
  7. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation. First author DOI 10.1111/cas.13610↗
  8. Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3… First author DOI 10.18632/oncotarget.25599↗
  9. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma. First author DOI 10.1111/cas.13119↗
  10. Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma. First author DOI 10.18632/oncotarget.18261↗
  11. The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster. First author DOI 10.18632/oncotarget.19591↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tetsuya Idichi · 11 shared papers, 2017–2023 · strength 1.02
  2. Hiroshi Kurahara · 11 shared papers, 2017–2023 · strength 1.02
  3. Takao Ohtsuka · 4 shared papers, 2020–2023 · strength 0.52
  4. Kosei Maemura · 7 shared papers, 2017–2019 · strength 0.50
  5. Shoji Natsugoe · 7 shared papers, 2017–2019 · strength 0.50
  6. Yuko Mataki · 6 shared papers, 2017–2019 · strength 0.43
  7. Yuto Hozaka · 3 shared papers, 2020–2021 · strength 0.34
  8. Takako Tanaka · 3 shared papers, 2020–2021 · strength 0.34
  9. Haruhi Fukuhisa · 4 shared papers, 2018–2019 · strength 0.31
  10. Keiichi Yonemori · 3 shared papers, 2017 · strength 0.19
  11. Kosuke Fukuda · 1 shared paper, 2023 · strength 0.18
  12. Pramod Nepal · 1 shared paper, 2021 · strength 0.12
  13. Hiroki Shimomura · 1 shared paper, 2020 · strength 0.11
  14. Muhammad Khalid · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.